药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dobutamine
4-Hydroxytestosterone
The risk or severity of edema formation can be increased when 4-Hydroxytestosterone is combined with Dexamethasone.
Dobutamine
1-Testosterone
The risk or severity of edema formation can be increased when 1-Testosterone is combined with Dexamethasone.
Dobutamine
Bolasterone
The risk or severity of edema formation can be increased when Bolasterone is combined with Dexamethasone.
Dobutamine
19-norandrostenedione
The risk or severity of edema formation can be increased when 19-norandrostenedione is combined with Dexamethasone.
Dobutamine
Nandrolone phenpropionate
The risk or severity of edema formation can be increased when Nandrolone phenpropionate is combined with Dexamethasone.
Dobutamine
Trilostane
The risk or severity of edema formation can be increased when Trilostane is combined with Dexamethasone.
Dobutamine
Osimertinib
The metabolism of Osimertinib can be increased when combined with Dexamethasone.
Dobutamine
Phenylacetic acid
The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Dexamethasone.
Dobutamine
Glycerol phenylbutyrate
The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Dexamethasone.
Dobutamine
Phenylbutyric acid
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Dexamethasone.
Dobutamine
Benzoic acid
The therapeutic efficacy of Benzoic acid can be decreased when used in combination with Dexamethasone.
Dobutamine
Alcuronium
The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Dexamethasone.
Dobutamine
Gallamine
The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Dexamethasone.
Dobutamine
Atracurium
The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Dexamethasone.
Dobutamine
Neosaxitoxin
The risk or severity of myopathy and weakness can be increased when Neosaxitoxin is combined with Dexamethasone.
Dobutamine
Pyrantel
The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Dexamethasone.
Dobutamine
Rapacuronium
The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Dexamethasone.
Dobutamine
Vecuronium
The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Dexamethasone.
Dobutamine
Metocurine
The risk or severity of myopathy and weakness can be increased when Metocurine is combined with Dexamethasone.
Dobutamine
Mivacurium
The risk or severity of myopathy and weakness can be increased when Mivacurium is combined with Dexamethasone.